Memery Crystal is the city law firm instrumental in opening up the London market to medicinal cannabis companies, having recently steered the listing of MGC Pharma (LON:MXC).
CEO Nick Davis joins Proactive London's Katie Pilbeam to explain the growing interest in life science companies and why now is the time for this sector to list. Davis explains that he has been waiting for the 'right quality' medical cannabis companies to come along.
In general, he says 'the London capital markets have been very strong' and supportive of life sciences firms.
